Westport Resources Management’s Virtus Biotech Clinical Trials ETF BBC Stock Holding History

Westport Resources Management’s Portfolio BBC Stock Details BBC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	$23K	Buy	+1,000	New	+$20.5K	0.02%	369

Other funds holding BBC

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

CCP

Cardan Capital Partners Denver, Colorado $893M AUM 22.82% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

LTFS

Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return

MFS

MSI Financial Services Springfield, Massachusetts $3.07B AUM 10.22% 1-Year Est. Return

Westport Resources Management's BBC Position: Q3 2016 in Review

Westport Resources Management opened a new position in Virtus Biotech Clinical Trials ETF (BBC) in Q3 2016: 1,000 shares worth $23K. The stake represents 0.02% of the portfolio and ranks #369 among its holdings.

13 funds tracked by Wall St. Rank hold BBC as of Q3 2016.

Westport Resources Management held 1,000 shares of Virtus Biotech Clinical Trials ETF worth $23K as of Q3 2016.
Virtus Biotech Clinical Trials ETF was a new Westport Resources Management position in Q3 2016.
Virtus Biotech Clinical Trials ETF made up 0.02% of Westport Resources Management's portfolio in Q3 2016, its #369 holding.
13 funds tracked by Wall St. Rank held Virtus Biotech Clinical Trials ETF as of Q3 2016.

Based on Westport Resources Management's 13F filing for Q3 2016, filed 14 Nov 2016.